Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression

Parkinson's disease (PD) is associated with emotional abnormalities. Dopaminergic medications ameliorate Parkinsonian motor symptoms, but less is known regarding the impact of dopaminergic agents on affective processing, particularly in depressed PD (dPD) patients. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Anders H., Smith, Charles D., Slevin, John T., Kryscio, Richard J., Martin, Catherine A., Schmitt, Frederick A., Blonder, Lee X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697088/
https://www.ncbi.nlm.nih.gov/pubmed/26793404
http://dx.doi.org/10.1155/2015/513452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697088/
https://www.ncbi.nlm.nih.gov/pubmed/26793404
http://dx.doi.org/10.1155/2015/513452

Ejemplares similares